Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine model

被引:11
作者
Buscaglia, J. M. [1 ]
Simons, B. W. [2 ]
Prosser, B. J. [1 ]
Ruben, D. S. [2 ]
Giday, S. A. [1 ]
Magno, P. [1 ]
Clarke, J. O. [1 ]
Shin, E. J. [1 ]
Kalloo, A. N. [1 ]
Kantsevoy, S. V. [1 ]
Gabrielson, K. L. [1 ]
Jagannath, S. B. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA
关键词
D O I
10.1055/s-2007-995653
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and study aims: Pancreatitis complicates 1%-22% of endoscopic retrograde cholangiopancreatography procedures. The study aims were to develop a reproducible animal model of post-ERCP pancreatitis (PEP), and investigate the impact of endoscopic technique on severity of PEP. Patients and methods: ERCP was carried out in six male hound dogs. Pancreatitis was induced by one of three escalating methods: 1) pancreatic acinarization with 20-30 mL of contrast; 2) acinarization + ductal balloon occlusion + sphincterotomy; 3) acinarization + intraductal synthetic bile injection + ductal balloon occlusion + sphincterotomy. Dogs 5 and 6 received a pancreatic stent. Necropsy was performed on postoperative day 5. All pancreatic specimens were graded by two blinded pathologists according to a validated scoring system. All dogs were compared with three control dogs. Results: Dogs 1-4 developed clinical pancreatitis and hyperamylasemia (11736 vs. 722 U/L, P=0.02). Total injury scores were significantly elevated compared with controls (6.85 vs. 1.06, P= 0.004). There was significant increase in acinar cell necrosis (0.86 vs. 0.06, P= < 0.001), and all other categories (except fibrosis) demonstrated elevated injury scores. Dogs 5 and 6 developed clinical pancreatitis without significant hyperamylasemia; total injury scores were elevated compared with controls (4.83 vs. 1.06, P= 0.01), but lower than in Dogs 1-4 (4.83 vs. 6.85, P= 0.25). There was escalating severity of pancreatic injury from Dogs 1 to 4 correlating with the method of endoscopic injury used. Conclusion: Severity of PEP is directly proportional to invasiveness of endoscopic intervention. Pancreatic acinarization, even without balloon occlusion and sphincterotomy, can be used as a reliable animal model for future studies investigating therapy and prevention of disease.
引用
收藏
页码:506 / 512
页数:7
相关论文
共 50 条
[1]   Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis [J].
Andriulli, A ;
Leandro, G ;
Niro, G ;
Mangia, A ;
Festa, V ;
Gambassi, G ;
Villani, MR ;
Facciorusso, D ;
Conoscitore, P ;
Spirito, F ;
De Maio, G .
GASTROINTESTINAL ENDOSCOPY, 2000, 51 (01) :1-7
[2]   Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial [J].
Arvanitidis, D ;
Anagnostopoulos, GK ;
Giannopoulos, D ;
Pantes, A ;
Agaritsi, R ;
Margantinis, G ;
Tsiakos, S ;
Sakorafas, G ;
Kostopoulos, P .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (03) :278-282
[3]  
BILBAO MK, 1976, GASTROENTEROLOGY, V70, P314
[4]   DOES THE SOMATOSTATIN ANALOG OCTREOTIDE PROTECT AGAINST ERCP INDUCED PANCREATITIS [J].
BINMOELLER, KF ;
HARRIS, AG ;
DUMAS, R ;
GRIMALDI, C ;
DELMONT, JP .
GUT, 1992, 33 (08) :1129-1133
[5]   Experimental model of obstructive, chronic pancreatitis in pigs [J].
Boerma, D ;
Straatsburg, IH ;
Offerhaus, GJA ;
Gouma, DJ ;
van Gulik, TM .
DIGESTIVE SURGERY, 2003, 20 (06) :520-526
[6]   Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography:: results of a randomized study [J].
Bordas, JM ;
Toledo-Pimentel, V ;
Llach, J ;
Elena, M ;
Mondelo, F ;
Ginès, A ;
Terés, J .
GASTROINTESTINAL ENDOSCOPY, 1998, 47 (03) :230-234
[7]   A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis [J].
Budzynska, A ;
Marek, T ;
Nowak, A ;
Kaczor, R ;
Nowakovska-Dulawa, E .
ENDOSCOPY, 2001, 33 (09) :766-772
[8]   Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography [J].
Cavallini, G ;
Tittobello, A ;
Frulloni, L ;
Masci, E ;
Mariani, A ;
DiFrancesco, V ;
Angelini, GP ;
Casarini, MB ;
Bedogni, G ;
Conigliaro, R ;
Bonardi, L ;
Khajekini, MTA ;
Cipolletta, L ;
Bianco, MA ;
Costamagna, G ;
Perri, V ;
Dobrilla, G ;
DePretis, G ;
Familiari, L ;
Giacobbe, G ;
Fratton, A ;
Carone, N ;
Loriga, P ;
Muscas, A ;
Mazzeo, F ;
Gaeta, L ;
Miglioli, M ;
Pezzilli, R ;
Morelli, A ;
Santucci, L ;
Naccarato, R ;
DelFavero, G ;
Orlandi, F ;
Macarri, GP ;
Russo, A ;
Virgilio, C ;
Uomo, G ;
Manes, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13) :919-923
[9]  
Chen Jie, 2004, Zhonghua Yi Xue Za Zhi, V84, P1726
[10]   Risk factors for post-ERCP pancreatitis: A prospective multicenter study [J].
Cheng, CL ;
Sherman, S ;
Watkins, JL ;
Barnett, J ;
Freeman, M ;
Geenen, J ;
Ryan, M ;
Parker, H ;
Frakes, JT ;
Fogel, EL ;
Silverman, WB ;
Dua, KS ;
Aliperti, G ;
Yakshe, P ;
Uzer, M ;
Jones, W ;
Goff, J ;
Lazzell-Pannell, L ;
Rashdan, A ;
Temkit, M ;
Lehman, GA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) :139-147